million barda grant vaccin phase ii summer
announc new million grant biomed advanc research
develop author barda mrna vaccin novel
coronaviru agreement barda fund fda
licensur fund enabl hire employe manufactur scale-
norwood facil includ vaccin procur nih conduct
phase studi complet enrol healthi adult three
dose cohort nih recent ad six addit cohort
assess older adult age year elderli adult age year
pend safeti begin phase ii studi summer
set potenti phase trial start fall reiter overweight rate
increas price target
proj ev billion cash
phase coronaviru vaccin data summer nih complet enrol
phase studi healthi volunt assess safeti
immunogen subject receiv two dose either
administ day apart protocol recent amend
studi enrol six new cohort includ three cohort older adult age
year three cohort elderli adult age year preliminari safeti
immunogen data protein expect late spring
earli summer
phase ii studi summer phase trial fall intend file
ind conduct phase iia studi studi confirm
dose safeti immunogen could begin larger pivot trial
earli fall continu work supplier stock raw materi
scale oper norwood make million dose barda grant fund
late-stag program well scale-up manufactur year
meet pandem respons support manufactur effort hire
employe year
mrna therapeut novel could fail clinic gain approv
drug may reach sale forecast compani may invest project
develop innov mrna medicin
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
reiter overweight rate increas price target
increas valu vaccin pipelin mrna platform roll forward
discount period new price target base increas
project enterpris valu billion billion
valu cmv vaccin billion million appli
standard multipl sale billion discount back lower
rate valu vaccin million
million appli multipl sale billion discount back
lower valu pediatr rsv vaccin million
million appli multipl sale billion discount back
view discount rate appropri
valu merck-partn rsv vaccin million million
appli multipl royalti million discount back
view multipl appropri higher margin royalti
discount rate appropri phase vaccin
today increas valu novel coronaviru vaccin
billion million base new barda contract potenti govern
stockpil increas valu moderna zika vaccin million
million base posit phase data earlier week continu add
million epstein-barr viru vaccin million influenza
vaccin chikungunya vaccin chikungunya
antibodi today ad billion valu vaccin platform
continu valu merck-partn person cancer vaccin billion
valu merck-partn kra vaccin million million
appli multipl share sale million discount back
continu add million valu wholly-own intratumor
phase ii ovarian cancer studi valu wholly-own intratumor
melanoma tripl neg breast cancer
billion billion appli multipl sale billion
discount back view discount rate high phase
intratumor cytokin therapi could adjust data year continu add
million astrazeneca-partn preclin intratumor
due delay orphan diseas clinic studi due push
approv year valu methylmalon acidemia mma
billion appli multipl sale million discount back
prior valu methylmalon acidemia mma
billion appli multipl sale million discount back
valu propion acidemia pa million appli
multipl sale million discount back prior
valu wholly-own propion acidemia pa million appli
multipl sale million discount back valu
pku million appli multipl sale billion
discount back prior valu pku billion
appli multipl sale billion discount back
view discount rate appropri phase ind cleared/readi orphan
diseas program continu add million fabri diseas
million diseas million total addit preclin
page
add million wholly-own preclin immun system program
today ad billion moderna
lead mrna pipelin intellectu properti manufactur capabl
valu share astra-zeneca partner myocardi ischemia
million million appli multipl royalti million
discount back view multipl appropri higher
margin royalti discount rate appropri phase ii intra-myocardi mrna
program add million az-partn preclin relaxin heart failur
estim hold pro forma cash billion million share
outstand add estim cash million prior net
cash billion divid increas project market cap billion
million share arriv new price target pleas see exhibit
piper sandler comani estim
page
thousand except per share data
compani report piper sandler estim
current disclosur inform compani found
